Not known Details About Ceftriaxone
MI-CP151 was a phase 1b randomised, double-blind, placebo managed, dose-escalation, multicentre study To guage multiple intravenous doses of sifalimumab, in adult clients with dermatomyositis or polymyositis (NCT00533091). Main demo aims were To guage the security and tolerability of sifalimumab in dermatomyositis or polymyositis individuals, altho